Vbi Vaccines Inc (VBIV) - News Archive

Strategic Restructuring and Legal Proceedings: VBI Vaccines Inc. s Current Landscape and Future Prospects The biotechnology sector is marked by rapid innovation and occasional turbulence, as evidenced by recent events a...

This article provides an in-depth examination of the recent restructuring proceedings of VBI Vaccines Inc. (Nasdaq: VBIV) as it navigates financial challenges and seeks to stabilize its operations. Following the initial...

In a significant development within the biopharmaceutical sector, VBI Vaccines Inc. (NASDAQ: VBIV), known for its immunology-driven breakthroughs, has taken decisive steps to navigate financial headwinds as it implement...

CAMBRIDGE, Mass. VBI Vaccines Inc. (Nasdaq: VBIV), a biopharmaceutical company focused on immunology and dedicated to pioneering solutions for the prevention and treatment of diseases, has recently provided important up...

VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Facilitate Strategic Alternatives In a significant development for VBI Vaccines Inc. (Nasdaq: VBIV), a leading biopharmaceutical company focused on immunolo...

VBI Vaccines Reports Successful Shareholder Voting Results and Promising Interim Data on Cancer Vaccine at ASCO Annual MeetingCambridge-based biopharmaceutical company, VBI Vaccines Inc. (Nasdaq: VBIV), recently announc...

VBI Vaccines, a biopharmaceutical company at the forefront of immunotherapy and vaccine development, recently announced promising interim tumor response data from their ongoing randomized, controlled Phase 2b study of V...

VBI Vaccines Inc., a leading biopharmaceutical company dedicated to revolutionizing disease prevention and treatment through immunology, recently announced the acceptance of new interim tumor response data from their Ph...

VBI Vaccines Reports First Quarter 2024 Financial Results and Outlines Key Business StrategiesIn the pursuit of offering robust disease prevention and treatment solutions, VBI Vaccines Inc. has released its financial re...